Metformin Reverses Progesterone Resistance in Endometrial Cancer by Targeting the AMPK-FOXO1-CALB2 Pathway.

已完结 20 由 JDK 发布于 2026/5/28 10:48:50

DOI:10.2174/0109298673492535260512101635
作者：Liangli Hong, Ruilin Lin, Weifeng Zhang, Jiwei Jiao, Chuan Wang, Hongrong Wu, Yong Liao, Qianchen Qiu, Qi Xie and Jiang Gu*
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.2174/0250688202666210402094638

Bentham Science

Abstract：Introduction: Progesterone therapy is standard for fertility-preserving endometrial cancer (ECC) patients, but primary and secondary resistance limit its efficacy. Metformin (MET) combined w

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Taylor & FrancisSustainable probiotic production via AI: medium optimization and metabolic mechanisms in <i>Bifidobacterium animalis</i> ssp. <i>lactis</i> BB-12 using agricultural waste.